A new weapon against the super-tough C diff bacteria tested in phase-one human trial
In a phase-one human clinical trial, a University of Houston pharmacist researcher has demonstrated that a newer generation tetracycline antibiotic, called Omadacycline, may be a promising tool in combating the resilient ...
Dec 19, 2023
0
2
